• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Outlook Therapeutics Inc (NQ: OTLK )

    7.470 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 7.470
    Bid (Size) 7.470 (2)
    Ask (Size) 8.750 (2)
    Prev. Close 7.470
    Today's Range 7.470 - 7.470
    52wk Range 4.004 - 29.20
    Shares Outstanding 23,655,636
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    OTLK Stock Earnings: Outlook Therapeutics Beats EPS for Q3 2024
    OTLK stock results show that Outlook Therapeutics beat analyst estimates for earnings per share the third quarter of 2024. 
    Via InvestorPlace
    3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices
    Beaten-down stocks offer value to investors, but not all are worth buying. This is a look at three biopharma at long-term lows with catalysts for higher prices. 
    Via MarketBeat

    Performance

    YTD
    -4.99%
    -4.99%
    1 Month
    -6.63%
    -6.63%
    3 Month
    -5.86%
    -5.86%
    6 Month
    -15.67%
    -15.67%
    1 Year
    -70.82%
    -70.82%

    More News

    Read More
    3 Undervalued Gems Set to Soar 1,000% by 2026
    Via InvestorPlace
    MarketBeat Week in Review – 6/17 - 6/21
    Via MarketBeat
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
    Via MarketBeat
    OTLK Stock Earnings: Outlook Therapeutics Misses EPS for Q2 2024
    Via InvestorPlace
    Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
    Via InvestorPlace
    Insiders Buying Outlook Therapeutics And 2 Other Stocks
    Via Benzinga
    Gold Moves Lower; Lululemon Shares Plummet
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Dow Dips 200 Points; Nike Shares Fall After Q3 Results
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Higher On Friday?
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Over $1.7M Bet On Globalstar? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    7 of the Best Speculative Stocks You Can Snag for Less Than $1
    Via InvestorPlace
    7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    OTLK DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal Product Safety
    OTLK DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action – OTLK
    From The Rosen Law Firm, P.A.
    Via Business Wire
    OTLK IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal Product Safety
    OTLK DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OTLK
    From The Rosen Law Firm PA
    Via GlobeNewswire
    OTLK DEADLINE ALERT: ROSEN, A LEADING AND RANKED FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal Product Safety
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.